News
While Pacific Biosciences' earnings were beat, shrinking sales, high debt, and poor macro environment do not inspire ...
Element has responded to the lawsuit with a statement saying, “Element is proud of its strong history of innovation. We are ...
Todd Friedman; Senior Director of Investor Relations; Pacific Biosciences of California Inc Christian Henry; President, Chief Executive Officer, Director; Pacific Biosciences of California Inc Jim ...
Q1 2025 Earnings Call Transcript May 8, 2025 Pacific Biosciences of California, Inc. beats earnings expectations. Reported ...
We sell different types of products and services to both investment professionals and individual investors. These products and services are usually sold through license agreements or subscriptions ...
The Department of the Air Force’s process for determining if airmen and Space Force guardians should receive medical waivers for shaving is about as indecipherable as the infamous flow chart ...
The analytical power and versatility of today’s laser-based flow cytometry systems have unlocked the mysteries of cell biology and empowered entirely new fields of research. As a result ...
Pacific Biosciences of California (PACB ... It aims for a consumable pull-through of $300,000 per system and is targeting cash flow positivity by the end of 2027.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results